HIV

In the Lab By Shayla Love

Genetic fossil-hunters dig through HIV’s long history for clues to new treatments

In the Lab By Andrew Joseph

A drug used to treat Crohn’s disease could suppress HIV, monkey study suggests

Health By Dylan Scott

In Trump’s America, towns in poor health don’t think he will save them

Heavyweights By Rebecca Robbins

The drug pricing crusader at the center of one of the nastiest fights of the election season

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FDA approves a biosimilar version of Enbrel

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Glaxo believes its plan for HIV treatment is a ‘game changer’

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Another analysis finds new cholesterol drugs are not cost-effective

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: Gilead’s preventive HIV pill must be covered in England

Health By Lindzi Wessel

High rates of injection drug use increases gay teens’ HIV risk

First Opinion By Peter Piot and Mitchell Warren

Prevention must be at the forefront to meet global HIV goals

Health By Ike Swetlitz

HIV drugs protect against transmission, even in unprotected sex

Pharmalot By Ed Silverman

Gilead’s new price hikes on HIV drugs anger AIDS activists

Business By Rebecca Robbins

Gilead hikes price of HIV therapies, other drugs by up to 10 percent

In the Lab By Eric Boodman

Inside a monkey lab, research gets fast-tracked in the ‘Zika room’

First Opinion By Benjamin Mazer

We are not viruses: Don’t limit gay men from donating blood

First Opinion By Anthony S. Fauci and Deborah L. Birx

An AIDS-free world is possible, but do we have the will to achieve it?

Health By Helen Branswell

HIV rates soar among Southern men who have sex with men